Most Read This Week
- Risk of Esophageal Adenocarcinoma in Patients With Barrett’s Esophagus: Antireflux Surgery vs Antireflux Medications
- Abnormal GI Motility Can Explain Symptoms and Be a Potential Therapeutic Target in Patients With Disorders of Gut–Brain Interaction
- Efficacy of Dupilumab in Patients With Severe, Treatment-Refractory, and Fibrostenotic Eosinophilic Esophagitis
- Spectrum and Impact of Metabolic Dysfunction in Patients With MAFLD
- Association of Being Breastfed in Infancy With the Risk of Colorectal Cancer and Precursor Lesions
Recently Updated
- Natural History of NASH Cirrhosis in Liver Transplantation Waitlist Registrants
- Acute Pancreatitis May Progress to Chronic With Sustained Heavy Alcohol Use
- 5-ASA Discontinuation Common Within First Year of Ulcerative Colitis Diagnosis in Youth
- Risk for Esophageal Adenocarcinoma Not Increased With Nonerosive GERD
- Revaccination Suggested for Hep B Vaccine Nonresponders After Hep C Cure